It will be a while before UFC fans see Isabela de Padua again.
The Brazilian flyweight fighter made her octagon debut back in November against Ariane Lipski, coming up short in a three-round unanimous decision loss to the “Violence Queen.” To add insult to injury, USADA (the U.S. Anti-Doping Agency) announced Thursday that de Padua had been handed a two-year sanction following a pair of positive drug tests.
De Padua (5-2), 28 years old, tested positive for 19-norandrosterone (19-NA), a primary urinary metabolite of nandrolone (19-nortestosterone). Nandrolone is an anabolic steroid, banned at all times under the UFC’s anti-doping policy.
The initial positive came in-competition, on November 16, 2019. That was followed by another positive on December 19 in an out-of-competition test.
Carbon isotope-ratio mass spectrometry (GC/C/IRMS) analysis was used to verify that the source of the banned substance was exogenous. As de Padua did not list any medication containing the substance prior to joining the UFC last year, she’s been handed a full two-year suspension from competition.
“De Padua’s two-year period of ineligibility began on November 16, 2019, the date her first positive sample was collected,” USADA noted in Thursday’s press release. “As the regulatory body that sanctioned de Padua’s bout on November 16, 2019, the Comissao Atletica Brasileira de MMA (CABMMA) has recognized USADA’s sanction subject to any additional fines it may impose in accordance with the CABMMA Anti-Doping Policy.”
